HUGEL
DEAD

Serial Number

79261502

Owner

HUGEL INC.

Filing Date

May 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HUGEL Trademark

Serial Number: 79261502

HUGEL is a trademark filed by HUGEL INC. on May 2, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

HUGEL INC. (23 trademarks)

23, Geodudanji 1-gil, Dongnae- myeon,

Entity Type: 03

Trademark Details

Filing Date

May 2, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; drugs for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, pharmaceutical preparations comprising botulinum toxin, fragments of botulinum toxin; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating dystonia; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for the treatment of pain; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for use in treating urogenital system diseases and conditions; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; appetite suppressants for medical purposes; medicated lotions for treating dermatological conditions; ointments for pharmaceutical purposes; analgesics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; vaccines; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid; medical gels for activation of tissues, namely, medical gels for hypodermic syringes for improving wrinkles; hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; modified hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; injectable dermal fillers; pre-filled syringes for medical purposes, namely, prefilled with pharmaceutical preparations in the nature of hyaluronic acid, modified hyaluronic acid, its derivatives or substances that have a similar effect to hyaluronic acid, for the treatment and management of skin and soft tissue or artificial prostheses

Medical apparatus and instruments; medical apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments for plastic surgery; medical apparatus and instruments for the treatment of skin; sutures; suture for medical purpose; syringes for medical purposes and for injections; medical filler apparatus; medical filler syringes; dermatoplastic instruments; surgical instruments for use in cosmetic surgery and plastic surgery for skin; skin esthetic massaging apparatus; orthopaedic articles; dental apparatus and instruments; gloves for use in hospitals; masks for medical purposes; dermic implants for medical use, intended for filling of wrinkles or increasing volume; syringes for injecting medical substances for the skin, namely, used for the injection of hyaluronic acid for contouring lips and faces, scar correction and wrinkle reduction for medical purposes

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 14, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 2, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 2, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 12, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 25, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 25, 2020 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 2, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 2, 2020 ABN2
REFUSAL PROCESSED BY IB
Sep 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 27, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 24, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 23, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 29, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 20, 2019 SDRC